Ae
Aerovate Ther
Cambridge MAFounded 201930 employees
Private CapbiotechAcquiredPulmonology
Platform: Imatinib inh PAH
Market Cap
N/A
All Drugs
2
Clinical Trials
2
Failed / Terminated
0
FDA Approved
0
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Talacapivasertib | AER-2412 | Phase 1/2 | 1 | SOS1 | RettLN | ||
| Miricapivasertib | AER-2560 | NDA/BLA | 1 | DLL3 | EoENASH |
Financial Documents
This company has been acquired — see parent company for financial filings.
Catalyst Events (2)